etisulergine has been researched along with apomorphine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nordmann, R; Petcher, TJ | 1 |
Nordmann, R; Widmer, A | 1 |
Agnati, LF; Andersson, K; Fuxe, K; Hökfelt, T; Köhler, C; Kuonen, D; Ogren, SO | 1 |
3 other study(ies) available for etisulergine and apomorphine
Article | Year |
---|---|
Octahydrobenzo[g]quinolines: potent dopamine agonists which show the relationship between ergolines and apomorphine.
Topics: Animals; Apomorphine; Ergolines; Female; Male; Pregnancy; Quinolines; Rats; Receptors, Dopamine; Structure-Activity Relationship | 1985 |
Resolution and absolute configuration of the potent dopamine agonist N,N-diethyl-N'-[(3 alpha, 4a alpha, 10a beta)-1,2,3,4,4a,5,10,10a- -octahydro-6-hydroxy-1-propyl-3-benzo[g]quinolinyl]sulfamide.
Topics: Aminoquinolines; Animals; Apomorphine; Crystallography; Male; Molecular Conformation; Rats; Receptors, Dopamine; Stereoisomerism; Structure-Activity Relationship | 1985 |
Characterization of normal and supersensitive dopamine receptors: effects of ergot drugs and neuropeptides.
Topics: Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Brain; Bromocriptine; Caudate Nucleus; Corpus Striatum; Ergolines; Kinetics; Organ Specificity; Pergolide; Putamen; Rats; Receptors, Dopamine | 1981 |